GMC Terrain is all new with bold styling, a high-tech interior, and an extensive list of advanced driver assist features.

After a major overhaul for the 2024 model year, there are few changes with GMC’s Acadia three-row SUV for 2025.

The Trailering Package is now standard on all trim levels of the 2025 GMC Acadia, rather than being an option for the entry-level Elevation trim as in 2024.

Prices shown for the used 2013 GMC Acadia Wagon 4D Denali AWD with NaN miles are what people paid to buy this vehicle or what people received when trading in this vehicle at a dealer. Edit options.

Zipp's 303 Firecrest wheelset has been around for almost half a decade yet its goldilocks design means it's still one of the best gravel wheelsets you can buy. When our product tester Guy Kesteven ...

That same electric platform allows all four wheels to steer, a feature GMC will never let you forget is called "Crabwalk," athropod iconography and all. On the realistic end, it does allow the ...

The GMC Sierra Denali arrived near the start of Y2K, and with it came a game-changing notion: what if hard-working capability could be opulent? This notion has since influenced many of the models ...

Misses from amyotrophic lateral sclerosis hopefuls Denali Therapeutics and partners AbbVie and Calico Life Sciences mark the latest setbacks for the controversial platform trial, the results from ...

It integrates large 400 mm brake discs in a 21-inch rim, making it ideal for the front wheels of high-performance vehicles where space and weight are crucial factors. The Sonic.1 delivers a continuous ...

Tenvie Therapeutics has unveiled with $200 million and the goal of transforming the neurological treatment landscape, nabbing several programs—and an executive—from Denali Therapeutics.

A new company is making hay from an R&D shift at Denali Therapeutics, acquiring several of its neuroscience drug candidates and raising money from one of its original investors. The biotech ...

Tenvie Therapeutics has launched with $200 million and a clutch of assets from Denali Therapeutics to go after neurological diseases with small molecules. Backed by ARCH Venture Partners, F-Prime ...